Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.80 Issue 2 / 2017
  4. Article
Original Articles
Views

Arq. Bras. Oftalmol. 2017; 80 (2): 10.5935/0004-2749.20170019

Total: 1144

Evaluation of nicotinamide as an anti-inflammatory and anti-angiogenic agent in uveal melanoma cell lines

Evangelina Esposito1; Sultan Aldrees1; Christina Mastromonaco1; Pablo Zoroquiain1; Natalia Vila1; Patrick T. Logan1; Shriya Hari1; Miguel N. Burnier1

DOI: 10.5935/0004-2749.20170019

1 Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Quebec, Canada.

2 Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.


Read in Portuguese XML Print PDF English
Open Access
Share

How to cite this article:

Evangelina Esposito , Sultan Aldrees , Christina Mastromonaco , Pablo Zoroquiain , Natalia Vila , T. Logan P, et al. Avaliação da nicotinamida como agente anti-inflamatório e anti-angiogênico em linhas celulares de melanoma uveal. Arq. Bras. Oftalmol. 2017;80(2):. 10.5935/0004-2749.20170019
Export citation